Resources
Latest resources
Webinars
The Devil Is In The Details – A Checklist For Developing Successful Eu Pharma And Medtech Forecasts
Forecasting the value of biopharmaceutical and MedTech assets often begins with the US market, given its size and significance.
White Papers
Payers and the Inflation Reduction Act
A view into how twelve large national and regional payers are preparing for the IRA, and what their planning means for the future of pharmaceutical forecasting.
White Papers
Optimizing Early-Stage Commercial Assessments for Emerging Biopharma
A guide to sizing commercial assessments at each stage of asset development, from early exploration through detailed decision modeling, for emerging biopharma navigating limited resources and high-stakes funding decisions.
White Papers
Payers and the Inflation Reduction Act
A view into how twelve large national and regional payers are preparing for the IRA, and what their planning means for the future of pharmaceutical forecasting.
White Papers
The Upcoming Crowded Pipeline Crisis and What to Do About It
A look at why pharmaceutical pipelines are doubling without matching sales growth, and the modern forecasting tools needed to value pipeline assets in increasingly crowded markets.
Strategic Asset Scouting for Portfolio Accretion
A structured, analytics-driven approach to identify and prioritize high-value BD&L opportunities across therapeutic areas.
Case Studies
Early-Stage Demand Research
Global demand study for an early-stage oncology treatment in a high unmet need category.
Case Studies
Global Launch Forecast Modeling
Global launch forecast planning for an oncology asset – a successful establishment of robust forecast capabilities across regions, enabling smooth launch forecast planning
Engage with Us
Whether your seeking a career or to work with us on a project, we’re excited to chat!
